资讯 | 美股收盘基本持平,纳指结束三连涨

wechat omage

美股

北京时间11月7日凌晨,美股周三收盘基本持平,纳指结束此前连续三个交易日上涨的行情。投资者继续关注国际贸易关系方面的不确定性因素、美企财报及并购消息等。

截止收盘,道指收盘下跌0.07点,报27492.56点;标普500指数涨2.16点,或0.07%,报3076.78点;纳指跌24.05点,或0.29%,报8410.63点。

受油价下跌影响,道指成份股埃克森美孚(71.49, -1.60, -2.19%)公司(XOM)下跌2.2%,雪佛龙(119.9, -2.04, -1.67%)公司(CVX)下跌1.7%。

周三投资者密切关注几位美联储官员的讲话与新一轮企业财报。美企财报季接近尾声。据FactSet数据显示,迄今为止已公布财报的标准普尔500强公司中,75%的业绩超出了分析师的预期。

芝加哥联储总裁查尔斯-埃文斯(Charles Evans)、纽约联储总裁约翰-威廉姆斯(22.24, -0.71, -3.09%)(John Williams)等美联储官员在周三发表了讲话。

埃文斯表示,美联储今年三度降息使美国经济处于良好状态。他称:“我认为我们已经做出了很好的调整,考虑到了风险管理方面的顾虑。制定的政策有利于应对经济面临的实际风险。我认为将通货膨胀率控制在2%是适宜的。”

美联储官员上周投票决定今年第三次降息25基点。美联储列出降息的理由包括贸易政策不确定性、全球经济增长放缓、通胀低于目标等因素。

埃文斯表示:“我绝对认为现在的经济状况良好。消费者开支非常强劲,最新数据反映了这一点。”

焦点个股:

CVS (CVS)宣布,受到去年收购的Aetna人寿保险部门推动,其盈利与营收均强劲增长。营收增长37%,达648.1亿美元,市场预期630.1亿美元。经过调整后的每股收益为1.84美元,较市场平均预期值高出7美分。

日本软银集团(SoftBank Group)报告称,其盈利受到办公空间共享初创公司WeWork的拖累,公司蒙受巨额损失。

Coty(COTY)宣布第一财季盈利超出预期,但营收稍逊预期。旗下奢侈品与消费级美容产品销售不及预期,抵消了专业级美容产品业绩超预期的影响。

优步(UBER)的首次公开募股后锁定期于周三结束,将有市值超过200亿美元的限售股份面临解禁,约占总流通市值的84%左右。这是5月份公开发行股票后,该公司早期的投资者和员工将能够出售其股票的第一天。该公司周一宣布第三季度的营收和营收均好于预期,并预测到2021年在调整后的EBITDA基础上将实现盈利。
 

   

港股

北京时间11月6日,美股周二收盘涨跌不一。道指与纳指小幅收高,二者均刷新了历史最高收盘纪录。标普500指数小幅收跌。市场仍在权衡国际贸易协议的前景、乐观的经济数据以及美国联邦政府关门的可能性。周三开盘,港股恒指低开0.17%,盘中一度翻红。

截至收盘,恒生指数涨0.02%,报27688.64点。国企指数跌0.15%,报10860.86点;红筹指数跌0.74%,报4398.68点。

热点板块:

蒙牛乳业(30.5, -1.90, -5.86%)跌5.86%,报30.5港元,领跌蓝筹。高盛引述蒙牛料本季毛利率会受压,因原料成本上升。

蓝筹地产股上涨。新世界发展(11.62, 0.14, 1.22%)涨1.22%;长实集团(55.2, 0.40, 0.73%)涨0.73%;新鸿基地产(121.3, 0.80, 0.66%)涨0.66%。

中资券商股下跌。中信建投跌2.58%;国泰君安(12.52, -0.32, -2.49%)跌2.49%;广发证券(8.74, -0.19, -2.13%)跌2.13%。

苹果概念股下跌。东江集团跌2.53%;高伟电子(1.28, -0.03, -2.29%)跌2.29%;丘钛科技(10.72, -0.22, -2.01%)跌2.01%。

长江生命科技(0.9, 0.55, 153.52%)股价暴涨153.52%,报0.9港元,最新市值85.5亿港元。长江生命科技宣布,旗下美国附属公司Polynoma的黑色素瘤抗原疫苗免疫疗法研究的中期数据分析结果,将于本周五(8日)在美国马里兰州举行的癌症免疫疗法学会2019年会中首度展出。nbsp;

中国A股

北京时间11月6日,早盘两市小幅高开后弱势震荡,权重板块表现乏力,锂电池板块热点延续,南北船、特斯拉等板块表现强势,区块链、猪肉等板块走弱,临近午盘半导体板块下挫。午后三大股指单边下行,深证成指一度跌超1%,沪指、创业板指同步走弱,临近尾盘,指数小幅回升。整体上,市场情绪不佳,题材热点全线萎靡,赚钱效应较差,成交量萎缩。个股方面跌多涨少,涨停股仅20余只,科创板昊海生科、久日新材两只股出现破发。北向资金则延续净流入态势。

截止收盘,沪指报2978.6点,跌0.43%,深成指报9860.97点,跌0.78%。

从盘面上看,军工、稀有金属、钢铁等板块涨幅居前,猪肉、ETC、半导体等板块跌幅居前。

热点板块:

军工板块领涨两市,截止收盘,三角防务(36.150, 3.29, 10.01%)、中航飞机(16.600, 1.51, 10.01%)、江龙船艇(13.420, 1.22, 10.00%)等封涨停板,中国卫通(10.900, 0.53, 5.11%)、中船科技(14.390, 0.77, 5.65%)、航发科技(14.910, 0.69, 4.85%)、中国应急(11.260, 0.44, 4.07%)等个股跟涨。

消息面上11月5日晚间,中航飞机公告称,拟将部分飞机零部件制造业务资产与中航飞机有限责任公司(下称航空工业飞机)部分飞机整机制造及维修业务资产进行置换。华创证券指出,重组完成后,中航飞机将更加聚焦整机主业,成为我国主要的大中型运输机、轰炸机、特种飞机等飞机产品的制造商,以及C919、ARJ21、AG600以及国外民用飞机的重要供应商,是大飞机领域的主力军。

猪肉板块领跌两市,截止收盘,天邦股份(13.800, -1.28, -8.49%)逼近跌停,天域生态(10.060, -0.96, -8.71%)、正邦科技(15.480, -1.02, -6.18%)、傲农生物(19.350, -1.03, -5.05%)、天康生物(14.150, -0.75, -5.03%)、正虹科技(6.060, -0.33, -5.16%)等个股跌幅居前。

农业农村部官网发布信息称,据农业农村部信息中心和山东卓创资讯股份有限公司联合监测,2019年第44周(即10月28日-11月1日),16省(直辖市)瘦肉型白条猪肉出厂价格总指数的周平均值为每公斤52.93元,环比跌0.9%,同比涨187%。据悉,这也是国内瘦肉型白条猪肉出厂价格、自8月份以来,首次出现环比下跌。
 
如果有想了解更多全球股市资讯,请关注微信公众号 “辉立资本新加坡” (SGPSPL)

同时提供在线免费开设股票账户,一个账户轻松交易美股,港股,新加坡股,中国A股,越南股票,韩国股票,德国股票,马来西亚股票,泰国股票,印尼股票,菲律宾股票,日本股票,澳大利亚股票,台湾股票,加拿大股票,英国股票,法国股票,荷兰股票,葡萄牙股票,比利时股票,土耳其股票
 

来源:东方财富网,新浪财经,同花顺,21世纪经济报道,彭博,华尔街见闻,辉立证券

联系我们开设账户

需要帮助吗?请分享您的详细资料,我们会给您答复。

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com